The objective of this study is to characterize initial treatment burden in oncology patients, by assessing health resource utilization (HRU) and dose modification, with and without active symptom monitoring.
A career change can often come with uncertainty for the future, but for Christina Morgan, Clinical Practice Transformation Advisor at Carevive, it gave her a voice to advocate for cancer patients helping them receive the highest quality of care. Oncology and Technology host Tyler Kern sat with Morgan to discuss her transition from the field of nursing to clinical practice.
The ONS Congress brings together various skillsets and inspires innovation in new ways. With the first in-person Congress since the pandemic set to begin on April 27th, there is much to look forward to. John Elliott, VP of Sales with Carevive brings together his work colleagues to share their excitement for the Congress and what they think might come f
Carevive is excited to present and exhibit at ISPOR 2022 on May 15–18, 2022. The theme for this year will be a “green thread” that is woven throughout the sessions to bring a fresh and holistic view into the future of HEOR in patient-driven digital healthcare systems. The last two years have seen a rapid rise of real-time solutions, digital…
Kristen Dininno, RN, Carevive’s Account Manager, sat down with Elizabeth Coleman, RN, BSN, OCN, Nurse Manager Ascension Borgess Cancer Center, to chat about what Ascension hopes to gain from using Carevive’s cancer care management tools.
Carevive Systems and Blue Spark Technologies announce partnership to conduct real-time remote patient monitoring pilot across three sites. The study will integrate Carevive’s expertise in Patient-Reported Outcomes (ePROs) data with Blue Spark’s disruptive TempTraq continuous wearable remote temperature monitoring solution
Datavant and Carevive announce partnership to de-identify and connect Carevive’s oncology patient experience data (SMART Data™) in order to support life sciences companies engaged in health economics and outcomes research, clinical development planning, and post-market observational studies.
Carevive Vice President of Sales John Elliott joined host David Kemp to discuss how trade shows have provided the oncology and wider healthcare industry with value and started the year off on the right foot in 2022.